• Balsalazide Disodium: Targeted 5-ASA Prodrug for Ulcerative

  2026-06-19

  The reference study systematically evaluates balsalazide disodium, a targeted prodrug of 5-aminosalicylic acid, for its efficacy and safety in the treatment of active ulcerative colitis. The findings highlight its unique colonic activation, rapid induction of remission, and favorable tolerability, informing both clinical and preclinical inflammation research.

• Lysosomal β-Galactosidase Staining Kit: Precision in Senesce

  2026-06-18

  The Lysosomal β-Galactosidase Staining Kit offers artifact-free, polystyrene-compatible detection of lysosomal enzyme activity, crucial for controlling and validating senescence studies. Its optimized workflow and specificity enable reproducible, high-fidelity results in both basic and translational cancer research.

• Cyclophosphamide Applications: Protocols, Innovations & Trou

  2026-06-18

  Cyclophosphamide's versatility as an alkylating chemotherapeutic agent makes it indispensable for cancer research, apoptosis induction, and immune modulation. Discover optimized workflows, advanced applications, and expert troubleshooting tips to maximize reproducibility and translational impact, leveraging APExBIO's high-purity Cyclophosphamide.

• Repurposing FDA-Approved Drugs to Modulate DNA Repair in CRI

  2026-06-17

  This study systematically screens FDA-approved drugs to identify modulators of DNA double-strand break (DSB) repair pathways during CRISPR genome editing. The findings reveal actionable compounds that shift repair outcomes, inform synthetic lethality strategies, and have broad implications for gene therapy, cancer research, and drug repositioning screening.

• NO-Releasing Tranexamic Acid Dressings for Rapid Trauma Hemo

  2026-06-17

  This study introduces a bi-layer wound dressing combining tranexamic acid, a nitric oxide donor, and propolis to achieve instant clot formation and strong antibacterial effects in traumatic injuries. The innovation demonstrates both enhanced hemostasis and infection control, offering a promising advancement for emergency wound care and antifibrinolytic agent research.

• Applied PX-478 2HCl: Experimental Workflows in Hypoxia Resea

  2026-06-16

  PX-478 2HCl, a potent HIF-1α inhibitor, empowers researchers to dissect hypoxia-driven pathways from cancer biology to neurodevelopmental disorders. This guide translates recent breakthroughs, including ASD models, into actionable protocols and troubleshooting tactics for robust bench success.

• 2-(4,5,6,7-Tetrabromo) Small Molecule Inhibitor in Kinase Re

  2026-06-16

  Unlock precise control over protein kinase-driven phase separation using the CK2 and ERK8 inhibitor, a high-purity, DMSO-soluble small molecule tool. This guide delivers optimized experimental workflows, troubleshooting insights, and practical applications, empowering researchers to dissect complex enzyme interactions with confidence.

• Plk1-Mediated Regulation of p31comet in Mitotic Checkpoint D

  2026-06-15

  This study reveals how Polo-like kinase 1 (Plk1) phosphorylates p31comet to regulate the disassembly of mitotic checkpoint complexes (MCC) and control mitotic progression. By defining a phosphorylation-dependent inhibition of p31comet, the findings clarify a key mechanism in chromosome segregation fidelity with implications for targeting mitotic regulators in cell cycle research.

• HRP Rabbit Anti-Goat IgG (H+L) Antibody: Precision in Immuno

  2026-06-15

  Unlock unmatched sensitivity for immunodetection of goat primary antibodies using the HRP Rabbit Anti-Goat IgG (H+L) Antibody. This guide translates cutting-edge research into actionable protocols and troubleshooting strategies to elevate your ELISA, IHC, and western blot workflows.

• Veratridine as a Precision Neurotoxin: Advanced Insights for

  2026-06-14

  Explore how Veratridine, a voltage-gated sodium channel opener, advances sodium channel dynamics and excitotoxicity research. This article uniquely dissects mechanistic and assay design implications, providing expert guidance for neuroscience and oncology workflows.

• USP42 Drives Breast Cancer Progression via JNK/p38 Inhibitio

  2026-06-13

  The referenced study reveals that ubiquitin-specific peptidase 42 (USP42) promotes breast cancer progression by suppressing apoptosis through inhibition of the JNK and p38 MAPK signaling pathways. This mechanistic insight positions USP42 as a potential target for breast cancer therapy and underscores the significance of DUBs in tumor biology.

• Phosphatase Inhibitor Cocktail 3: Precision in Phosphoproteo

  2026-06-12

  Explore how Phosphatase Inhibitor Cocktail 3 enables rigorous protein phosphorylation preservation for advanced phosphoprotein analysis. This article reveals nuanced mechanisms and practical protocols that distinguish its use in signaling research.

• Doxycycline Hyclate: Strategic MMP Inhibition for Neurovascu

  2026-06-12

  This article explores the mechanistic and translational significance of doxycycline hyclate as a matrix metalloproteinases inhibitor, with a focus on preserving blood-brain barrier (BBB) integrity and mitigating cognitive impairment in preclinical neurovascular models. We synthesize recent in vivo evidence, detail protocol parameters for translational workflows, critically assess the competitive and domain-bridging landscape, and offer a forward-looking perspective for researchers targeting MMP-2 and MMP-9-mediated pathologies.

• GLP-1 (9-36) amide: Precision in GLP-1 Receptor Antagonist R

  2026-06-11

  GLP-1 (9-36) amide empowers researchers to dissect GLP-1 receptor signaling with unmatched specificity, enhancing GPCR pathway studies in metabolic and diabetes research. This guide delivers actionable protocols, troubleshooting strategies, and interpretive insights grounded in the latest high-throughput FRET assay innovation.

• BMP4-GPX4 Axis Mitigates Ferroptosis in Glaucoma Stem Cell M

  2026-06-11

  This study demonstrates that BMP4-driven upregulation of GPX4 alleviates ferroptosis in retinal ganglion cells and enhances the differentiation of transplanted retinal stem cells in a mouse model of high intraocular pressure glaucoma. These findings introduce a mechanistic basis for targeting the BMP4-GPX4 pathway to improve neuroprotection and stem cell therapy outcomes in glaucoma.

450 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page